News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioMidwest
Amgen CEO: Tough Road Ahead For Diabetes-Drug Development
November 2, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CLEVELAND -(Dow Jones)- Amgen Inc. (AMGN) Chief Executive Kevin Sharer said Monday he doesn't envision the drug industry developing new medicines over the next decade that fundamentally stem the rising tide of diabetes.
Twitter
LinkedIn
Facebook
Email
Print
Amgen
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
·
3 min read
·
Greg Slabodkin
BioMidwest
Top 5 Companies Hiring in Illinois
May 29, 2024
·
1 min read
·
Angela Gabriel
Business
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq
April 26, 2024
·
2 min read
·
Tyler Patchen
